U.S. court voids $448 million award against AbbVie, AndroGel partner

Ruling in a case brought by the Federal Trade Commission, the 3rd U.S. Circuit Court of Appeals in Philadelphia said the lower court judge who ordered the disgorgement by AbbVie and Besins Healthcare Inc lacked authority under applicable federal law. The appeals court also upheld an order finding AbbVie and Besins liable for monopolization, based upon its holding that they had filed a sham patent infringement lawsuit against Perrigo Co to delay the launch of generic AndroGel. …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.